Update in Pulmonary Hypertension 2005
- 1 March 2006
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 173 (5) , 499-505
- https://doi.org/10.1164/rccm.2512003
Abstract
No abstract availableThis publication has 93 references indexed in Scilit:
- Simvastatin enhances bone morphogenetic protein receptor type II expressionBiochemical and Biophysical Research Communications, 2006
- Adult patients with congenital heart disease and pulmonary arterial hypertension: First open prospective multicenter study of bosentan therapyAmerican Heart Journal, 2005
- Human Herpesvirus 8 and Pulmonary HypertensionEmerging Infectious Diseases, 2005
- High lung PDE5: A strong basis for treating pulmonary hypertension with PDE5 inhibitorsBiochemical and Biophysical Research Communications, 2005
- Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in childrenBiochemical and Biophysical Research Communications, 2005
- Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial HypertensionCirculation Research, 2005
- Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics: Table. 1—European Respiratory Journal, 2005
- Decreased Whole Body Endogenous Nitric Oxide Production in Patients with Primary Pulmonary HypertensionJournal of Vascular Research, 2005
- Survival with first-line bosentan in patients with primary pulmonary hypertensionEuropean Respiratory Journal, 2005
- Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertensionThe FASEB Journal, 2004